RIO DE JANEIRO, BRAZIL - Preliminary studies suggest the AstraZeneca vaccine will protect against the P1 variant of the coronavirus, Mauricio Zuma, the head of production at Brazil’s Fiocruz biomedical institute said on Monday, confirming a Reuters report on Friday, March 8th.
The Brazil variant is worrying experts because it is highly contagious and has led several countries to ban travel from the Latin American nation.
. . .
To read the full NEWS and much more, Subscribe to our Premium Membership Plan. Already Subscribed? Login Here